Therapeutic potential of cytokine and chemokine antagonists in cancer therapy
- 1 April 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (6) , 793-802
- https://doi.org/10.1016/j.ejca.2006.01.013
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Rapid onset of cutaneous squamous cell carcinoma of the penis in a patient with psoriasis on etanercept therapyJournal of the American Academy of Dermatology, 2004
- Aggressive cutaneous T-cell lymphomas after TNFα blockadeJournal of the American Academy of Dermatology, 2004
- A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patientsSupportive Care in Cancer, 2004
- CXCR4 and CXCL12 (SDF-1) in Prostate CancerClinical Cancer Research, 2004
- A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanomaBiochemical and Biophysical Research Communications, 2004
- Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximabJournal of the American Academy of Dermatology, 2004
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- Cachexia in cancer patientsNature Reviews Cancer, 2002
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999